A Contract DEevelopment and Manufacturing Organization (SDMO), is an organization that serves the pharmaceutical industry and provides clients with comprehensive services from drug development though manufacture.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Pharmaceutical CDMO Services industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Drug Substance Development and Manufacturing
Specialized Services
Lab-based Services
Market Segment by Product Application
Innovative Medicine
Patented Drug
Patent Expired Drug
Finally, the report provides detailed profile and data information analysis of leading company.
Recipharm AB
Strides Pharma Science Limited
Aenova Group
AMRI Global
WuXi AppTec Group
Patheon N.V.
Siegfried Ltd
Amatsigroup
Catalent, Inc.
Piramal Pharma Solutions
Fareva Group
FAMAR Health Care Services
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Pharmaceutical CDMO Services consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Pharmaceutical CDMO Services market by identifying its various subsegments.
3.Focuses on the key global Pharmaceutical CDMO Services manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Pharmaceutical CDMO Services with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Pharmaceutical CDMO Services submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Pharmaceutical CDMO Services Professional Survey Report Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Pharmaceutical CDMO Services Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Pharmaceutical CDMO Services Segment by Type
2.1.1 Drug Substance Development and Manufacturing
2.1.2 Specialized Services
2.1.3 Lab-based Services
2.2 Market Analysis by Application
2.2.1 Innovative Medicine
2.2.2 Patented Drug
2.2.3 Patent Expired Drug
2.3 Global Pharmaceutical CDMO Services Market Comparison by Regions (2017-2027)
2.3.1 Global Pharmaceutical CDMO Services Market Size (2017-2027)
2.3.2 North America Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.3 Europe Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.4 Asia-pacific Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.5 South America Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.3.6 Middle East & Africa Pharmaceutical CDMO Services Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Pharmaceutical CDMO Services Industry Impact
2.5.1 Pharmaceutical CDMO Services Business Impact Assessment - Covid-19
2.5.2 Market Trends and Pharmaceutical CDMO Services Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Pharmaceutical CDMO Services Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Pharmaceutical CDMO Services Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Pharmaceutical CDMO Services Manufacturer Market Share
3.5 Top 10 Pharmaceutical CDMO Services Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Pharmaceutical CDMO Services Market
3.7 Key Manufacturers Pharmaceutical CDMO Services Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Pharmaceutical CDMO Services Industry Key Manufacturers
4.1 Recipharm AB
4.1.1 Company Details
4.1.2 Recipharm AB Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.1.3 Recipharm AB Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Recipharm AB News
4.2 Strides Pharma Science Limited
4.2.1 Company Details
4.2.2 Strides Pharma Science Limited Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.2.3 Strides Pharma Science Limited Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Strides Pharma Science Limited News
4.3 Aenova Group
4.3.1 Company Details
4.3.2 Aenova Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.3.3 Aenova Group Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Aenova Group News
4.4 AMRI Global
4.4.1 Company Details
4.4.2 AMRI Global Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.4.3 AMRI Global Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 AMRI Global News
4.5 WuXi AppTec Group
4.5.1 Company Details
4.5.2 WuXi AppTec Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.5.3 WuXi AppTec Group Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 WuXi AppTec Group News
4.6 Patheon N.V.
4.6.1 Company Details
4.6.2 Patheon N.V. Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.6.3 Patheon N.V. Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Patheon N.V. News
4.7 Siegfried Ltd
4.7.1 Company Details
4.7.2 Siegfried Ltd Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.7.3 Siegfried Ltd Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.5 Siegfried Ltd News
4.8 Amatsigroup
4.8.1 Company Details
4.8.2 Amatsigroup Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.8.3 Amatsigroup Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Amatsigroup News
4.9 Catalent, Inc.
4.9.1 Company Details
4.9.2 Catalent, Inc. Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.9.3 Catalent, Inc. Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Catalent, Inc. News
4.10 Piramal Pharma Solutions
4.10.1 Company Details
4.10.2 Piramal Pharma Solutions Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.10.3 Piramal Pharma Solutions Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Piramal Pharma Solutions News
4.11 Fareva Group
4.11.1 Company Details
4.11.2 Fareva Group Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.11.3 Fareva Group Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Fareva Group News
4.12 FAMAR Health Care Services
4.12.1 Company Details
4.12.2 FAMAR Health Care Services Pharmaceutical CDMO Services Product Introduction, Application and Specification
4.12.3 FAMAR Health Care Services Pharmaceutical CDMO Services Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 FAMAR Health Care Services News
5 Global Pharmaceutical CDMO Services Sales Categorized by Regions
5.1 Global Pharmaceutical CDMO Services Revenue, Sales and Market Share by Regions
5.1.1 Global Pharmaceutical CDMO Services Sales and Market Share by Regions (2017-2022)
5.1.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Regions (2017-2022)
5.2 North America Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
5.3 Europe Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
5.4 Asia-pacific Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
5.5 South America Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
5.6 Middle East & Africa Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
6 North America Pharmaceutical CDMO Services Market Size Categorized by Countries
6.1 North America Pharmaceutical CDMO Services Sales, Revenue and Market Share by Countries
6.1.1 North America Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
6.1.2 North America Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
6.1.3 United States Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
6.1.4 Canada Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
6.1.5 Mexico Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
6.2 North America Pharmaceutical CDMO Services Revenue (Value) by Manufacturers
6.3 North America Pharmaceutical CDMO Services Sales and Market Share by Type (2017-2022)
6.4 North America Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
7 Europe Pharmaceutical CDMO Services Market Size Categorized by Countries
7.1 Europe Pharmaceutical CDMO Services Sales, Revenue and Market Share by Countries
7.1.1 Europe Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
7.1.2 Europe Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
7.1.3 Germany Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
7.1.4 UK Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
7.1.5 France Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
7.1.6 Russia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
7.1.7 Italy Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
7.1.8 Spain Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
7.2 Europe Pharmaceutical CDMO Services Revenue (Value) by Manufacturers
7.3 Europe Pharmaceutical CDMO Services Sales and Market Share by Type (2017-2022)
7.4 Europe Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
8 Asia-Pacific Pharmaceutical CDMO Services Market Size Categorized by Countries
8.1 Asia-pacific Pharmaceutical CDMO Services Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
8.1.2 Asia-pacific Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
8.1.3 China Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
8.1.4 South Korea Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
8.1.5 Japan Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
8.1.6 Australia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
8.1.7 India Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
8.1.8 Southeast Asia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
8.2 Asia-pacific Pharmaceutical CDMO Services Revenue (Value) by Manufacturers
8.3 Asia-pacific Pharmaceutical CDMO Services Sales and Market Share by Type (2017-2022)
8.4 Asia-pacific Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
9 South America Pharmaceutical CDMO Services Market Size Categorized by Countries
9.1 South America Pharmaceutical CDMO Services Sales, Revenue and Market Share by Countries
9.1.1 South America Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
9.1.2 South America Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
9.1.3 Brazil Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
9.2 South America Pharmaceutical CDMO Services Sales and Market Share by Type (2017-2022)
9.3 South America Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
10 Middle East and Africa Pharmaceutical CDMO Services Market Size Categorized by Countries
10.1 Middle East and Africa Pharmaceutical CDMO Services Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
10.1.2 Middle East and Africa Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
10.1.3 GCC Countries Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
10.1.4 Turkey Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
10.1.5 Egypt Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
10.1.6 South America Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
10.2 Middle East and Africa Pharmaceutical CDMO Services Sales and Market Share by Type
10.3 Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
11 Global Pharmaceutical CDMO Services Market Segment by Type
11.1 Global Pharmaceutical CDMO Services Revenue, Sales and Market Share by Type (2017-2022)
11.1.1 Global Pharmaceutical CDMO Services Sales and Market Share by Type (2017-2022)
11.1.2 Global Pharmaceutical CDMO Services Revenue and Market Share by Type (2017-2022)
11.2 Drug Substance Development and Manufacturing Sales Growth Rate and Price
11.2.1 Global Drug Substance Development and Manufacturing Sales Growth Rate (2017-2022)
11.2.2 Global Drug Substance Development and Manufacturing Price (2017-2022)
11.3 Specialized Services Sales Growth Rate and Price
11.3.1 Global Specialized Services Sales Growth Rate (2017-2022)
11.3.2 Global Specialized Services Price (2017-2022)
11.4 Lab-based Services Sales Growth Rate and Price
11.4.1 Global Lab-based Services Sales Growth Rate (2017-2022)
11.4.2 Global Lab-based Services Price (2017-2022)
12 Global Pharmaceutical CDMO Services Market Segment by Application
12.1 Global Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
12.2 Innovative Medicine Sales Growth Rate (2017-2022)
12.3 Patented Drug Sales Growth Rate (2017-2022)
12.4 Patent Expired Drug Sales Growth Rate (2017-2022)
13 Global Pharmaceutical CDMO Services Market Forecast
13.1 Global Pharmaceutical CDMO Services Revenue, Sales and Growth Rate (2022-2027)
13.2 Pharmaceutical CDMO Services Market Forecast by Regions (2022-2027)
13.2.1 North America Pharmaceutical CDMO Services Market Forecast (2022-2027)
13.2.2 Europe Pharmaceutical CDMO Services Market Forecast (2022-2027)
13.2.3 Asia-Pacific Pharmaceutical CDMO Services Market Forecast (2022-2027)
13.2.4 South America Pharmaceutical CDMO Services Market Forecast (2022-2027)
13.2.5 Middle East & Africa Pharmaceutical CDMO Services Market Forecast (2022-2027)
13.3 Pharmaceutical CDMO Services Market Forecast by Type (2022-2027)
13.3.1 Global Pharmaceutical CDMO Services Sales Forecast by Type (2022-2027)
13.3.2 Global Pharmaceutical CDMO Services Market Share Forecast by Type (2022-2027)
13.4 Pharmaceutical CDMO Services Market Forecast by Application (2022-2027)
13.4.1 Global Pharmaceutical CDMO Services Sales Forecast by Application (2022-2027)
13.4.2 Global Pharmaceutical CDMO Services Market Share Forecast by Application (2022-2027)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Pharmaceutical CDMO Services Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Pharmaceutical CDMO Services Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Pharmaceutical CDMO Services
Figure Market Concentration Ratio and Market Maturity Analysis of Pharmaceutical CDMO Services
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Pharmaceutical CDMO Services Market Size by Type
Figure Global Market Share of Pharmaceutical CDMO Services by Type in 2021
Figure Drug Substance Development and Manufacturing Picture
Figure Specialized Services Picture
Figure Lab-based Services Picture
Table Global Pharmaceutical CDMO Services Market Size (Volume) by Application
Figure Innovative Medicine Picture
Figure Patented Drug Picture
Figure Patent Expired Drug Picture
Table Global Pharmaceutical CDMO Services Comparison by Regions (M USD) 2017-2027
Figure Global Pharmaceutical CDMO Services Market Size (Million US$) (2017-2027)
Figure North America Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure Asia-pacific Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure South America Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Figure Middle East & Africa Pharmaceutical CDMO Services Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Pharmaceutical CDMO Services Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Pharmaceutical CDMO Services Sales by Manufacturer (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Manufacturer in 2021
Table Global Pharmaceutical CDMO Services Revenue by Manufacturer (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue Market Share by Manufacturer in 2021
Table Global Pharmaceutical CDMO Services Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Pharmaceutical CDMO Services Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Pharmaceutical CDMO Services Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Pharmaceutical CDMO Services Market
Table Key Manufacturers Pharmaceutical CDMO Services Product Type
Table Mergers & Acquisitions Planning
Table Recipharm AB Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Recipharm AB
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Recipharm AB 2017-2022
Table Recipharm AB Main Business
Table Recipharm AB Recent Development
Table Strides Pharma Science Limited Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Strides Pharma Science Limited
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Strides Pharma Science Limited 2017-2022
Table Strides Pharma Science Limited Main Business
Table Strides Pharma Science Limited Recent Development
Table Aenova Group Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Aenova Group
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Aenova Group 2017-2022
Table Aenova Group Main Business
Table Aenova Group Recent Development
Table AMRI Global Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of AMRI Global
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of AMRI Global 2017-2022
Table AMRI Global Main Business
Table AMRI Global Recent Development
Table WuXi AppTec Group Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of WuXi AppTec Group
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of WuXi AppTec Group 2017-2022
Table WuXi AppTec Group Main Business
Table WuXi AppTec Group Recent Development
Table Patheon N.V. Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Patheon N.V.
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Patheon N.V. 2017-2022
Table Patheon N.V. Main Business
Table Patheon N.V. Recent Development
Table Siegfried Ltd Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Siegfried Ltd
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Siegfried Ltd 2017-2022
Table Siegfried Ltd Main Business
Table Siegfried Ltd Recent Development
Table Amatsigroup Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Amatsigroup
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Amatsigroup 2017-2022
Table Amatsigroup Main Business
Table Amatsigroup Recent Development
Table Catalent, Inc. Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Catalent, Inc.
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Catalent, Inc. 2017-2022
Table Catalent, Inc. Main Business
Table Catalent, Inc. Recent Development
Table Piramal Pharma Solutions Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Piramal Pharma Solutions
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Piramal Pharma Solutions 2017-2022
Table Piramal Pharma Solutions Main Business
Table Piramal Pharma Solutions Recent Development
Table Fareva Group Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of Fareva Group
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Fareva Group 2017-2022
Table Fareva Group Main Business
Table Fareva Group Recent Development
Table FAMAR Health Care Services Company Profile
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of FAMAR Health Care Services
Table Pharmaceutical CDMO Services Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of FAMAR Health Care Services 2017-2022
Table FAMAR Health Care Services Main Business
Table FAMAR Health Care Services Recent Development
Table Pharmaceutical CDMO Services Product Introduction, Application and Specification of
Figure Global Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table Global Pharmaceutical CDMO Services Sales by Regions (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Regions in 2021
Table Global Pharmaceutical CDMO Services Revenue by Regions (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue Market Share by Regions in 2021
Figure North America Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Europe Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Asia-pacific Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure South America Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Middle East & Africa Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure North America Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table North America Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
Table North America Pharmaceutical CDMO Services Sales Market Share by Countries (2017-2022)
Figure North America Pharmaceutical CDMO Services Sales Market Share by Countries in 2021
Table North America Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
Table North America Pharmaceutical CDMO Services Revenue Market Share by Countries (2017-2022)
Figure North America Pharmaceutical CDMO Services Revenue Market Share by Countries in 2021
Figure United States Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Canada Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Mexico Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Table North America Pharmaceutical CDMO Services Revenue by Manufacturer (2021)
Figure North America Pharmaceutical CDMO Services Revenue Market Share by Manufacturer in 2021
Table North America Pharmaceutical CDMO Services Sales by Type (2017-2022)
Table North America Pharmaceutical CDMO Services Sales Share by Type (2017-2022)
Table North America Pharmaceutical CDMO Services Sales by Application (2017-2022)
Table North America Pharmaceutical CDMO Services Sales Share by Application (2017-2022)
Figure Europe Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table Europe Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
Table Europe Pharmaceutical CDMO Services Sales Market Share by Countries (2017-2022)
Figure Europe Pharmaceutical CDMO Services Sales Market Share by Countries in 2021
Table Europe Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
Table Europe Pharmaceutical CDMO Services Revenue Market Share by Countries (2017-2022)
Figure Europe Pharmaceutical CDMO Services Revenue Market Share by Countries in 2021
Figure Germany Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure UK Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure France Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Russia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Italy Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Spain Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Table Europe Pharmaceutical CDMO Services Revenue by Manufacturer (2021)
Figure Europe Pharmaceutical CDMO Services Revenue Market Share by Manufacturer in 2021
Table Europe Pharmaceutical CDMO Services Sales by Type (2017-2022)
Table Europe Pharmaceutical CDMO Services Sales Share by Type (2017-2022)
Table Europe Pharmaceutical CDMO Services Sales by Application (2017-2022)
Table Europe Pharmaceutical CDMO Services Sales Share by Application (2017-2022)
Figure Asia-pacific Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Sales Market Share by Countries (2017-2022)
Figure Asia-pacific Pharmaceutical CDMO Services Sales Market Share by Countries in 2021
Table Asia-pacific Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Revenue Market Share by Countries (2017-2022)
Figure Asia-pacific Pharmaceutical CDMO Services Revenue Market Share by Countries in 2021
Figure China Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure South Korea Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Japan Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Australia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure India Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Southeast Asia Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Revenue by Manufacturer (2021)
Figure Asia-pacific Pharmaceutical CDMO Services Revenue Market Share by Manufacturer in 2021
Table Asia-pacific Pharmaceutical CDMO Services Sales by Type (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Sales Share by Type (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Sales by Application (2017-2022)
Table Asia-pacific Pharmaceutical CDMO Services Sales Share by Application (2017-2022)
Figure South America Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table South America Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
Table South America Pharmaceutical CDMO Services Sales Market Share by Countries (2017-2022)
Figure South America Pharmaceutical CDMO Services Sales Market Share by Countries in 2019
Table South America Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
Table South America Pharmaceutical CDMO Services Revenue Market Share by Countries (2017-2022)
Figure South America Pharmaceutical CDMO Services Revenue Market Share by Countries in 2019
Figure Brazil Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Table South America Pharmaceutical CDMO Services Sales by Type (2017-2022)
Table South America Pharmaceutical CDMO Services Sales Share by Type (2017-2022)
Table South America Pharmaceutical CDMO Services Revenue by Type (2017-2022)
Table South America Pharmaceutical CDMO Services Revenue Share by Type (2017-2022)
Table South America Pharmaceutical CDMO Services Sales by Application (2017-2022)
Table South America Pharmaceutical CDMO Services Sales Share by Application (2017-2022)
Figure Middle East and Africa Pharmaceutical CDMO Services Revenue and Growth Rate (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Sales (Volume) by Countries (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Countries (2017-2022)
Figure Middle East and Africa Pharmaceutical CDMO Services Sales Market Share by Countries in 2019
Table Middle East and Africa Pharmaceutical CDMO Services Revenue by Countries (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Revenue Market Share by Countries (2017-2022)
Figure Middle East and Africa Pharmaceutical CDMO Services Revenue Market Share by Countries in 2019
Figure GCC Countries Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Turkey Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure Egypt Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Figure South Africa Pharmaceutical CDMO Services Sales and Growth Rate (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Sales by Type (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Sales Share by Type (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Revenue by Type (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Revenue Share by Type (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Sales by Application (2017-2022)
Table Middle East and Africa Pharmaceutical CDMO Services Sales Share by Application (2017-2022)
Table Global Pharmaceutical CDMO Services Sales by Type (2017-2022)
Table Global Pharmaceutical CDMO Services Sales Market Share by Type (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Type in 2021
Table Global Pharmaceutical CDMO Services Revenue by Type (2017-2022)
Table Global Pharmaceutical CDMO Services Revenue Market Share by Type (2017-2022)
Figure Global Pharmaceutical CDMO Services Revenue Market Share by Type in 2019
Figure Global Drug Substance Development and Manufacturing Sales Growth Rate (2017-2022)
Figure Global Drug Substance Development and Manufacturing Price (2017-2022)
Figure Global Specialized Services Sales Growth Rate (2017-2022)
Figure Global Specialized Services Price (2017-2022)
Figure Global Lab-based Services Sales Growth Rate (2017-2022)
Figure Global Lab-based Services Price (2017-2022)
Table Global Pharmaceutical CDMO Services Sales by Application (2017-2022)
Table Global Pharmaceutical CDMO Services Sales Market Share by Application (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales Market Share by Application in 2021
Figure Global Innovative Medicine Sales Growth Rate (2017-2022)
Figure Global Patented Drug Sales Growth Rate (2017-2022)
Figure Global Patent Expired Drug Sales Growth Rate (2017-2022)
Figure Global Pharmaceutical CDMO Services Sales and Growth Rate (2022-2027)
Figure Global Pharmaceutical CDMO Services Revenue and Growth Rate (2022-2027)
Table Global Pharmaceutical CDMO Services Sales Forecast by Regions (2017-2022)
Table Global Pharmaceutical CDMO Services Market Share Forecast by Regions (2017-2022)
Figure North America Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Europe Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Asia-Pacific Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure South America Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Figure Middle East & Africa Sales Pharmaceutical CDMO Services Market Forecast (2022-2027)
Table Global Pharmaceutical CDMO Services Sales Forecast by Type (2022-2027)
Table Global Pharmaceutical CDMO Services Market Share Forecast by Type (2022-2027)
Table Global Pharmaceutical CDMO Services Sales Forecast by Application (2022-2027)
Table Global Pharmaceutical CDMO Services Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Ke
Recipharm AB
Strides Pharma Science Limited
Aenova Group
AMRI Global
WuXi AppTec Group
Patheon N.V.
Siegfried Ltd
Amatsigroup
Catalent, Inc.
Piramal Pharma Solutions
Fareva Group
FAMAR Health Care Services